INFINITY PHARMA
InactiveInactive; last annual accounts for fiscal year 2020.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2020 was due by 31-07-2021 and was filed on 25-05-2021, 67 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2020
67 d early
2019
61 d early
2018
76 d early
2017
69 d early
2016
68 d early
2015
51 d early
2014
45 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2020, full schema
Turnover
€5.82M▲ 11.3%
2019 · €5.23M
2018: €5.10M
2019: €5.23M
2018 → 2020
EBIT margin
6.9%▼ 4.0pp
2019 · 10.9%
2018: 13.5%
2019: 10.9%
2018 → 2020
Net result
€177k▼ 38.9%
2019 · €290k
2018: €394k
2019: €290k
2018 → 2020
Working capital
€1.48M▲ 15.0%
2019 · €1.29M
2018: €977k
2019: €1.29M
2018 → 2020
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line201820192020Trend
Turnover€5.10M-€5.23M▲ 2.6%€5.82M▲ 11.3%
Equity€1.02M-€1.31M▲ 28.5%€1.49M▲ 13.6%
Operating result€690k-€571k▼ 17.3%€405k▼ 29.1%
Net result€394k-€290k▼ 26.4%€177k▼ 38.9%
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2020 is 29% below 2019 and is the lowest result in the available series.
Balance-sheet composition
2020 in colour, 2019 as the grey bar beneath
Assets €3.22M
Fixed assets
€17k ▼ 43.7%
Current assets
€3.20M ▲ 15.5%
Equity and liabilities €3.22M
Equity
€1.49M ▲ 13.6%
Provisions
€4k ▼ 54.5%
Debt
€1.73M ▲ 16.4%
Debt's share of the balance-sheet total rises from 53.0% to 53.7%. Equity and debt are higher.
Key figures and ratios
EBITDA
€418k▼
2019 · €604k
Cash flow
€190k▼
2019 · €324k
Current ratio
1.86▼
2019 · 1.87
Quick ratio
1.47▲
2019 · 1.27
ROE
11.9%▼
2019 · 22.2%
ROA
5.5%▼
2019 · 10.4%
Interest coverage
27.21▼
2019 · 29.70
Debt ≤ 1 year
€1.72M▲
2019 · €1.48M
Income taxes
€86k▼
2019 · €153k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2020 against 2019 · 28 lines
Balance sheet
Code20192020
Assets
Total assets20/58€2.80M€3.22M▲
Fixed assets21/28€30k€17k▼
Intangible fixed assets21€8k€3k▼
Tangible fixed assets22/27€22k€14k▼
Financial fixed assets28€364€364=
Current assets29/58€2.77M€3.20M▲
Stocks and contracts in progress3€883k€681k▼
Amounts receivable within one year40/41€94k€22k▼
Cash at bank and in hand54/58€1.76M€2.49M▲
Equity and liabilities
Total equity and liabilities10/49€2.80M€3.22M▲
Equity10/15€1.31M€1.49M▲
Contributions10/11€100k€100k=
Reserves13€1.21M€1.39M▲
Profit (loss) carried forward14€2.01M€908k▼
Provisions and deferred taxes16€8k€4k▼
Amounts payable17/49€1.48M€1.73M▲
Amounts payable within one year42/48€1.48M€1.72M▲
Trade debts44€861k€1.23M▲
Income statement
Code20192020
Turnover70€5.23M€5.82M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€33k€13k▼
Operating profit (loss)9901€571k€405k▼
Recurring financial income75€309€80▼
Recurring financial charges65€127k€142k▲
Debt charges650€20k€15k▼
Profit (loss) for the period before taxes9903€444k€263k▼
Income taxes67/77€153k€86k▼
Profit (loss) for the period9904€290k€177k▼
Profit (loss) for the period to be appropriated9905€290k€177k▼
Timeline · acts, filings and financial milestones
2021
26-07
State Gazette act
Merger · Name change
Statutes amendment · Capital · Liesbet Degroote
25-05
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
27-04
State Gazette act
Board meeting · Power of attorney
Merger · Accounting effect
2020
31-12
Financial
Weakest financial yearnet €177k ▼38.9%
Net result drops to €177k, the lowest in the series.
31-05
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
16-05
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
23-05
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
24-05
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
2016
10-06
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
2015
16-06
NBB filing
Annual accounts filed
fiscal year 2014 · full schema
2014
04-07
NBB filing
Annual accounts filed
fiscal year 2013 · full schema
2013
26-06
NBB filing
Annual accounts filed
fiscal year 2012 · full schema
2012
31-05
NBB filing
Annual accounts filed
fiscal year 2011 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Structure & network
Acquisitions and mergers
1 transactionTaken over by:ACA PHARMA